Q2 saw an unexpected drop in North America Q2'21 was below expectations, with net sales of SEK 158m (-8.
Impressing volumes and profitability Lagercrantz continues to impress, both on sales and margins, wi...
All segments behind significant earnings beat Addtech reported an impressive set of numbers.
In Q2, Trianon was active in investments, including listed, shares, projects and building rights.
Serneke published a solid Q2 report, delivering EBIT growth of 248% q/q, beating our EBIT estimate b...
Lime’s Q2 numbers once again affirmed what we have said time and time again.
Broad-based recovery continued in Q2 eWork continues to recover well after a soft 2020, as it managed to beat our sales and EBIT forecasts b...
Sales +22% y-o-y and +13% vs. ABGSCe On the back of reopened societies, Doro reported a good quarter...
PE reported strong Q2 results with a robust underlying performance in all segments.
Redeye remains optimistic about the prospects of Stille following its Q2 report.
Redeye views the Q2 report for Tagmaster as a further step towards normalization as market condition...
Redeye maintains its optimistic view of RLS following today’s Q2 report and still believes that the ...
Rekordhög bruttomarginal i spåren av prishöjningar BE Group rapporterade ett underliggande rörelseresultat på 133 mkr (28) i Q2'21, till sto...
Ericsson annonserade nu på morgonen sin Q2-rapport som innehöll lite blandade nyheter.
Redeye sees an excellent Q1 21/22 report from Lagercrantz, where the organic growth and margins beat...
IRLAB has signed an exclusive global licensing agreement with Ipsen worth up to $363m for its lead asset, mesdopetam, which is currently in ...
Vi ger våra initiala syn på gårdagens transformativa nyhet att Irlab ingått ett globalt licensavtal ...
Redeye argues that Enea delivered strong Q2 numbers, especially on EBIT which was considerably above...
Stabila siffror Hyresintäkterna i Q2 uppgick till 1 451 mkr, en ökning med ca 9,6% y/y.
Nelly Group, the online fashion retailer, reports Q2 sales of SEK 396.
Redeye is positive to last night's acquisition which strengthens Enea’s position in cybersecurity, e...
Q2 details Sales SEK 94.1m (0% vs ABGSC 94.5m), adj.
Högsta orderingången någonsin... Med bred återhämtning i efterfrågan växte orderingången med mer än ...
Ensereptide riktas nu in mot ärrbildning efter kirurgi Promore Pharma antog i mars 2021 en ny strate...
Q2 details Sales SEK 407m (+13% vs. ABGSCe 361m). Group EBIT SEK 22m (+76% vs.
Redeye reinforces its positive view on Formpipe following a strong Q2 report with record-high ARR gr...
Lime’s Q2 numbers were strong with 21% top line growth (12% organic) and continued margin expansion ...
Q-linea's Q2 confirms that the ASTar launch is underway with initial sales and deliveries to the strategic global sales partner Thermo Fisch...
Orexo's DTx segment is still encountering challenges and Zubsolv sales continue to decline.
Redeye maintains its positive view on Orexo after the Q2 report.
